Pharmafile Logo
Pharmafocus logo
Advanced Search
ABPI image

Pharma underwrites medicines bill with £207 million

June 8, 2015
Manufacturing and Production, Sales and Marketing ABPI, NHS, PPRS, ahsn, brett wells

The Department of Health and the ABPI have confirmed a payment of £207 million from pharma to underwrite growth of …

News
Novo image

Novo Nordisk launches diabetes combination

June 8, 2015
Sales and Marketing Novo Nordisk, Xutolphy, ada, diabetes

Diabetes specialist firm Novo Nordisk has launched a new treatment in the UK which combines two of the Danish firm’s …

News

Does wearable technology really have the potential to enhance modern healthcare?

June 8, 2015
Medical Communications healthcare, wearable technology

The added value of wearable devices

Feature
Thought Leadership
Actelion image

Shire makes £12 billion move for Actelion

June 8, 2015
Sales and Marketing Actelion, Shire, brett wells, nps pharma

Not a week goes by without a big pharma merger story, and now it’s the turn of Dublin-headquartered Shire that …

News
kevin_sharer

Allied Minds appoints Amgen CEO to board

June 8, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing allied minds, kevin sharer

US science and tech development and commercialisation firm Allied Minds has appointed Kevin Sharer to its board of directors.  Sharer …

Appointment
ASCO image

ASCO 2015 roundup: immuno-oncology hits its stride

June 8, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASCO, BMS, CLL, pdl1

One year can make all the difference. The 2014 American Society of Clinical Oncology (ASCO) meeting took place just weeks …

Feature
xofigo image

NICE issues guidance for two prostate cancer drugs

June 5, 2015
Sales and Marketing Bayer, Ferring, NICE, firmagon, xofigo

NICE has published draft guidance for two prostate cancer drugs, recommending a Bayer medicine but rejecting one from Ferring Pharmaceuticals. …

News
Merck logo

Merck launches new antibiotic in the UK

June 5, 2015
Research and Development, Sales and Marketing AMR, Antibiotics, MSD, Merck, Sivextro, antimicrobial resistance, cubist, tedizolid phosphate

Merck has launched the first new drug in a class of antibiotics in the UK in almost 15 years, becoming …

News
Sprout pill

FDA advisors back female sexual disorder drug

June 5, 2015
Medical Communications, Research and Development, Sales and Marketing

An FDA advisory panel has backed a new drug intended to boost female sex drive, but warned that it must …

News
google image

Google advances health data collection initiative

June 5, 2015
Medical Communications, Sales and Marketing Apple, brett wells, google, healthkit, researchkit, studykit

Google is advancing a suite of applications known as ‘Study Kit’ that enable users to collect and share health information …

News
michael_mckelvey

inVentiv Health appoints industry veteran

June 5, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michael McKelvey, inVentiv Health

inVentiv Health has appointed Michael McKelvey as the president of its health clinical division and executive vice president.  McKelvey is …

Appointment
Stelara image

NICE U-turn on Janssen arthritis drug

June 4, 2015
Sales and Marketing Janssen, NICE, Stelara, psoriasis, uturn

NICE has performed a U-turn on Janssen’s Stelara and has now recommended the drug for the treatment of psoriatic arthritis. …

News

Amgen and Novartis tussle over biosimilar injunction

June 4, 2015
Sales and Marketing Amgen, FDA, Neupogen, Novartis

Novartis has begun its court battle with Amgen over its biosimilar of cancer drug Neupogen, which Amgen is trying to …

News
Sprout image

FDA to assess female libido drug

June 4, 2015
Sales and Marketing FDA, Sprout Pharmaceutical, flibanserin, libido

The FDA is inching closer to a historic approval of a drug in the US commonly dubbed ‘Viagra for women’. …

News

Astellas spending $760m on autoimmune tie-up

June 4, 2015
Sales and Marketing Astellas, anokion, brett wells, kanyos

Astellas Pharma and Anokion are to collaborate and develop new treatments for type 1 diabetes and celiac disease in a deal that could net …

News
catherine_moukheibir

Creabilis appoints board chairman

June 4, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Catherine Moukheibiras, creabilis

UK, Canterbury-based dermatology firm Creabilis has appointed Catherine Moukheibiras as the chairman of its board of directors. After an initial career in strategy …

Appointment

Featured Interview on Industrial Design of Auto Injectors

June 4, 2015
Sales and Marketing auto injectors, ondrugdelivery, shl group

The necessity for auto injector has been growing rapidly over the years, spurring a variety of innovative designs to meet …

Feature
Thought Leadership
Shire image

Shire earns EMA nod for constipation drug

June 3, 2015
Sales and Marketing EMA, Resolor, Shire, constipation

Shire has seen approval from the European Medicines Agency to extend the licence of its constipation drug Resolor for men …

News
Keytruda image

Merck tests new Keytruda combination

June 3, 2015
Research and Development, Sales and Marketing Merck, dynavax, keytruda

Merck is continuing to investigate Keytruda combinations as it signs a deal to test the drug with an immunotherapy from …

News
Perrigo image

Perrigo buys OTC products from GSK

June 3, 2015
Sales and Marketing GSK, GlaxoSmithKline, Mylan, Perrigo, Teva, brett wells

In an all-cash move with no financial details disclosed Perrigo is buying a portfolio of leading over-the-counter products from GlaxoSmithKline. …

News
The Gateway to Local Adoption Series

Latest content

Sandoz opens biosimilar development centre in Slovenia

June 19, 2026

Codis announces three senior business development appointments

June 18, 2026

US laboratory approval supports launch of lung cancer blood test

June 17, 2026

Study to examine ways of improving diabetes care for younger adults

June 16, 2026

Phase 2 endometriosis trial reaches recruitment milestone

June 15, 2026